Brief: Stoke Therapeutics Reports Fourth Quarter And 2022 Financial Results

Stoke Therapeutics

06/03/2023 12:52

March 6 (Reuters) - Stoke Therapeutics Inc  STOK.O :
    * STOKE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
    * STOKE THERAPEUTICS-ON TRACK TO PROVIDE ADDITIONAL SAFETY,
SEIZURE FREQUENCY DATA FROM PATIENTS WHO RECEIVED MULTIPLE 45MG
DOSES OF STK-001 IN MID-2023
    * DATA FROM MULTIPLE 70MG DOSES OF STK-001 ANTICIPATED IN
SECOND
HALF OF 2023
    * STOKE THERAPEUTICS: SEES TO COMPLETE PHASE 1/2A STUDIES OF
STK-001 IN CHILDREN,ADOLESCENTS WITH DRAVET SYNDROME IN2023 TO
START PHASE3 PROGRAM IN 2024
    * STRONG CASH POSITION WITH RUNWAY EXTENDED TO END OF 2025
    * QTRLY NET LOSS PER SHARE—BASIC AND DILUTED $0.65
    * Q4 EARNINGS PER SHARE VIEW $-0.70 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw20557Ta 
Further company coverage:  STOK.O 

 ((Reuters.Briefs@thomsonreuters.com;))